Abstract
Insulin and IGF-1 are two highly related growth factors which mediate pleiotropic cellular responses1–3. These hormones regulate their specific actions via binding to specific high affinity receptors on the plasma membrane of target cells. Similar to these growth factors, the receptors for insulin and IGF-1 share a high degree of structural and functional properties4–7. Both these receptors are classified as Type I receptors being composed of two a subunits and two β subunits which are disulfide-linked into an α2β2 heterotetrameric complex (Figure 1). The receptor subunits are initially synthesized as αβ polypeptide fusion precursor proteins which undergoes extensive co-and post-translational modifications8–12. The receptor Mr 155,000 αβ precursors undergoe co-translational acylation and Asn-linked glycosylation. As the precursor is processed from the endoplasmic reticulum through the trans-Golgi network, intramolecular disulfide bonds are formed linking the a subunit to the β subunit. During this time frame, two αβ fusion precursors non-covalently dimerize followed by proteolytic cleavage at a furin-like tetrabasic sequence which separates the a subunit from the β subunit. Finally, the dimerized αβ half-receptors become disulfide-linked through the a subunits coincident with the addition of terminal sialic acid residues and exposure of the native α2β2 heterotetrameric receptor on the cell surface membrane.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.M. Rechter and S.P. Nissley, The nature and regulation of the receptors for insulinlike growth factors, Annu. Rev. Physiol 47:425–442 (1985).
I.D. Goldfine, The insulin receptor; Molecular biology and transmembrane signaling,Endocrinol Rev. 8: 235–255 (1987).
S. Jacobs and P. Cuatrecasas, Insulin Receptors, Annu. Rev. Pharmacol. Toxicol. 23:461–479 (1983).
Y. Ebina, L. Ellis, K. Jarnagin, M. Edery, L. Graf, E. Clauser, J.-H. Ou, R. Masiarz, Y.W. Kan, I.D. Goldfine, R.A. Roth, and W.J. Rutter, The insulin receptor; Molecular biology and transmembrane signaling, Cell 40: 747–758 (1985).
A. Ulrich, J.R. Bell, E.Y. Chen, R. Herrera, L.M. Petruzzelli, T.J. Dull, A. Gray, L. Coussens, Y.-C. Liao, M. Tsubokawa, A. Mason, P.H. Seeburg, C.L. Grunfeld, O.M. Rosen, and J. Ramachandran, Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes, Nature . 313: 756–761 (1985).
G. Steele-Perkins, J. Turner, J.C. Edman, J. Hari, S.B. Pierce, C. Stover, W.J. Rutter, and R.A. Roth, Expression and characterization of a functional human insulin-like growth factor I receptor, J. Biol.Chem. 263: 11486–11492 (1988).
A. Ullrich, A. Gray, A.W. Tam, T. Yang-Feng, M. Tsubokawa, C. Collins, W.Henzel, T. LeBon, S. Kathuria, E. Chen, S.Jacobs, U. Francke, J. Ramachandran, and Y. Fujita-Yamaguchi, Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity, EMBO J. 5: 2503–2512 (1986).
E. Van Oberghen, M. Kasuga, M. LeCam, J.A. Hedo, A. Itin, and L.C. Harrison,Biosynthetic labeling of insulin receptor: Studies of subunits in cultured human IM-9 lymphocytes, Proc. Natl. Acad. Sci. USA . 78: 1052–1056 (1981).
J.B. Forsayeth, B. Maddux,and I.D. Goldfine, Biosynthesis and processing of the human insulin receptor, Diabetes . 35: 837–846 (1986).
J.A. Hedo, E. Collier, and A. Watkinson, Myristyl and palmityl acylation of the insulin receptor, J. Biol Chem. 262: 954–957 (1987).
P.J. Deutsch, C.F. Wan, O.M. Rosen, and C.S.Rubin, Latent insulin receptors and possible receptor precursors in 3T3-L1 adipocytes, Proc. Natl. Acad. Sci. USA. 80: 133–136 (1983).
G.V. Ronnett, P. Knutson, R.A. Kohanski, T.L. Simpson, and M.D. Lane, Role of glycosylation in the processing of newly translated insulin proreceptor in 3T3-L1 adipocytes, J. Biol. Chem. 259: 4566–4575 (1984).
A.S. Andersen, T. Kjeldsen, F.C. Wiberg, P.M. Christensen, J.S. Rasmussen, K. Norris, K.B. Moller, and N.P.H. Moller, Changing the insulin receptor to possess insulin-like growth factor I ligand specificity, Biochemistry. 29: 7363–7366 (1990).
T.A. Gustaf son, and W.J. Rutter, The cysteine-rich domains of the insulin and insulinlike growth factor I receptors are primary determinants of hormone binding specificity, J. Biol. Chem. 265: 18663–18667 (1990).
T. Kjeldsen, A.S. Andersen, F.C Wiberg, J.S. Rasmussen, L. Schaffer, P.Baischmidt, D.B. Moller, and N.P.H. Moller, The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site, Proc. Natl. Acad. Sci. USA. 88: 4404–4408 (1991).
R. Schumacher, L. Mosthaf, J. Schlessinger, D. Brandenburg, and A. Ullrich, Insulin and IGF1 binding specificity is determined by distinct regions of their cognate receptors, J. Biol. Chem. 266: 19288–19295 (1991).
B. Zhang, and R.A. Roth, A region of the insulin receptor important for ligand binding, Proc. Natl. Acad. Sci. USA. 88: 9858–9862 (1991).
C.C. Yip, C. Grunfeld, and I.D. Goldfine, Identification and characterization of the 1 igand-binding domain of insulin receptor by use of an anti-peptide antiserum against arnino acid sequence 241–251 of the alpha subunit, Biochemistry. 30: 695–701 (1991).
C.C. Yip, H. Hsu, R.G. Patel, H.M. Hawley, B.A. Maddux, and I.D. Goldfine, Localization of the insulin-binding site to the cysteine-rich region of the insulin receptor alpha-subunit, Biochem. Biophys. Res. Commun. 157: 321–329 (1988).
R. Rafaeloff, R. Patel, C.C. Yip, I.D. Goldfine, and D.M. Hawley, Mutation of the high cysteine region of the human insulin receptor α-subunit increases insulin receptor binding affinity and transmembrane signalling, J. Biol. Chem. 264: 15900–15904 (1989).
F. Wedekind, K. Baer-Pontzen, S. Bala-Mohan, D. Choli, H. Zahn, and D. Brandenburg, Hormone binding site of the insulin receptor: Analysis using photoaffinity-mediated avidin complexing, Biol. Chem. Hoppe-Seyler. 370: 251–258 (1989).
S.M. Waugh, E.E. DiBella, and P.F. Pilch, Isolation of a proteolytically derived domain of the insulin receptor containing the major site of cross-linking/binding, Biochemistry. 28: 3448–3455 (1989).
M. Fabry, E. Schaefer, L. Ellis, E. Kojro, Fahrenholz and D. Brandenburg, Detection of a new hormone contact site within the insulin receptor ectodomain by the use of a novel photoreactive insulin, J. Biol. Chem. 267: 8950–8956 (1992).
P. DeMeyts, J.-L. Gu, R.M. Shymko, B.E. Kaplan, G.I. Bell, and J.Whittaker, Identification of a ligand-binding region of the human insulin receptor encoded by the second exon of the gene, Mol. Endocrinol. 4: 409–416 (1990).
B. Cheathman, and C.R. Kahn, Cyseine 647 in the insulin receptor is required for normal covalent interaction between a and ß subunits in signal transduction, J. Biol. Chem. 267: 7108–7115 (1992).
H.E. Tornqvist, J.R. Gunsalus, R.A. Nemenoff, A.R. Frackelton, M.W. Pierce, and J. Avruch, Identification of the insulin receptor tyrosine residues undergoing insulin stimulated phosphorylation in intact rat hepatoma cells, J. Biol. Chem. 263: 350–359 (1988).
M.F. White, S.E. Shoelson, H. Keutmann, and C.R.Kahn, A cascade of tyrosine autophosphorylation in the ß-subunit activates the phosphotransferase of the insulin receptor, J. Biol. Chem. 263: 2969–2980 (1988).
H.Maegawa, J.M. Olefsky, S. Thies, D. Boyd, A. Ullrich, and D.A. McClain, Insulin receptors with defective tyrosine kinase inhibit normal receptor function at the level of substrate phosphorylation, J. Biol. Chem. 263: 12629–12637 (1988).
K.-T. Yu, and M.P. Czech, Tyrosine phosphorylation of insulin receptor ß subunit activates the receptor tyrosine kinase in intact H-35 hepatoma cells, J. Biol. Chem. 261: 4715–4722 (1986).
O.M. Rosen, R. Herrera, Y. Olowe, L.M. Petruzzelli, and M.H. Cobb, Phosphorylation activates the insulin receptor tyrosine protein kinase, Proc. Natl. Acad. Sci. USA. 80: 3237–3240 (1983).
R.A. Kohanski, and M.D. Lane, Kinetic evidence for activating and non-activating components of autophosphorylation of the insulin receptor protein kinase, Biochem. Biophys. Res. Commun. 134: 1312–1318 (1986).
L.J.Sweet, B.D. Morrison, P.A. Wilden, and J.E. Pessin, Insulin dependent intermolecular subunit communication, J. Biol. Chem. 262: 16730–16738 (1987).
D.A. McClain, H. Maegawa, J. Levy, T. Huecksteadt, T.J. Dull, A. Ullrich, and J.M. Olefsky, Properties of a human insulin receptor with a COOH-terminal truncation, J. Biol. Chem. 263: 8904–8911 (1988).
H. Maegawa, D.A. McCalin, G. Freidenberg, J.M. Olefsky, M. Napier, T. Lapari,T.J. Dull, J. Lee, and A. Ullrich, Properties of a human insulin receptor with a COOH-terminal truncation, J. Biol. Chem. 263: 8912–8917 (1988).
R.S. Thies, A. Ullrich, and D.A. McClain, Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor, J. Biol. Chem. 264: 12820–12825 (1989).
A. Ando, K. Momomura, K. Tobe, R. Yamamoto-Honda, H. Sakura, Y. Tamori, Y. Kaburagi, O. Koshio, Y. Akanuma, Y. Yazaki, M. Kasuga, and T. Kadowaki, Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine, J. Biol. Chem. 267: 12788–12796 (1992).
M.G. Myers, Jr., J.M. Backer, K. Siddle, and M.F. White, The insulin receptor functions normally in Chinese hamster ovary cells after truncation of the C terminus, J. Biol. Chem. 266: 10616–10623 (1991).
O.M. Rosen, After Insulin Binds, Science 237: 1452–1458 (1987).
C.R. Kahn, The molecular mechanism of insulin action, Ann, Rev. Med. 36: 429–451 (1985).
M.F. White, and C.R. Kahn, The Enzymes, Vol. XVII, pp. 456–502, P.D. Boyer and E.G. Krebs, Eds., Academic Press, Orlando, FL (1986).
C.K. Sung, B.A. Maddux, Hawley, D.M. and I.D. Goldfine, Monoclonal antibodies mimic insulin activation of ribosomal protein S6 kinase without activation of insulin receptor tyrosine kinase, J. Biol. Chem. 264: 18951–18959 (1989).
A. Debant, G. Ponzio, E. Clausen, and B. Rossi, Receptor cross-linking restores an insulin metabolic effect altered by mutation on tyrosine 1162 and tyrosine 1163, Biochemistry. 28: 14–17 (1989).
D.E. Moller, H. Benecke, and J.S. Flier, Biologic activities of naturally occurring human insulin receptor mutations. Evidence that metabolic effects of insulin can be mediated by a kinase-deficient insulin receptor mutant, J. Biol. Chem. 266:10995–11001 (1991).
W. Gottschalk, The pathway mediating insulin’s effects on pyruvate dehydrogenase bypasses the insulin receptor tyrosine kinase, J. Biol. Chem. 266: 8814–8819 (1991).
R.L.Hintz, A.V. Thorsson, G. Enberg, and K, Hall, IGFII binding on human lymphoid lines: Demonstration of a common high affinity receptor for insulin like peptides, Biochem. Biophys. Res. Commun. 127: 929–936 (1984).
H.A. Jonas, J.D. Newman, and L.C. Harrison, An atypical insulin receptor with high affinity for insulin-like growth factors copurified with placental insulin receptors, Proc. Natl. Acad. Sci. USA. \83: 4124–4128 (1986).
P.Misra, R.L. Hintz, and R. Rosenfeld, Structure and immunological characterization of insulin like growth factor II binding to IM-9 cells., J. Clin. Endocrinol Me tab. 63: 1400–1405 (1986).
S.E.Tollefson, K. Thompson, and D.J. Petersen, Separation of the high affinity IGF I receptor from low affinity binding sites by affinity chromatography, J. Biol. Chem. 262: 16461–16469 (1987).
T.K. Alexandrides, and R.J. Smith, A novel fetal insulin-like growth factor (IGF) I receptor, J. Biol Chem. 264: 12922–12930 (1989).
S.J.Casella, V.K. Han, A.J. D’Ercole, M.E. Svoboda, and J.J. Van Wyk, Insulin-like growth factor II binding to the type I somatomedin receptor: Evidence for two high affinity binding sites, J. Biol. Chem. 261: 9268–9273 (1986).
M.A. Soos, and K. Siddle, Immunological relationships between receptors for insulin and insulin-like growth factor I, Biochem. J. 263: 553–563 (1989).
M.A. Soos, J. Whittaker, R. Lammers, A. Ullrich, and K. Siddle, Receptors for insulin and insulin-like growth factor-I can form hybrid dimers, Biochem. J. 270: 383–390 (1990).
M.A. Soos, C.E. Field, and K. Siddle, Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity, Biochem. J. 290: 419–426 (1991).
C.P. Moxham, V. Duronio, and S. Jacobs, Insulin-like growth factor I receptor ß-subunit heterogeneity, J. Biol. Chem. 264: 13238–13244 (1989).
J.E. Chin, J.M. Tavare, L. Ellis, and R.A. Roth, Evidence for hybrid rodent and human insulin receptors in transfected cells, J. Biol. Chem. 266: 15587–15590 (1991).
R.S. Garofalo, and B. Barenton, Functional and immunological distinction between insulin-like growth factor I receptor subtypes in KB cells, J. Biol. Chem. 267: 11470–11475 (1992).
A.L. Frattali and J.E. Pessin, Relationship between a subunit ligand occupancy and ß subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors, J. Biol. Chem. 268: 7393–7400 (1993).
B. Moss, O. Elroy-Stein, T. Mizukami, W.A. Alexander, and T.R. Fuerst, New mammalian expression vectors, Nature. 348: 91–92 (1990).
A.L. Frattali, J.L. Treadway, and J.E. Pessin, Transmembrane signaling by the human insulin receptor kinase, J. Biol. Chem. 267: 19521–19528 (1992).
J. Lee, T. O’Hare, P.F. Pilch, and S.E. Shoelson, Insulin receptor autophosphorylation occurs asymmetrically, J. Biol. Chem. 268: 4092–4098 (1993).
J.L. Treadway, B.D. Morrison, M.A. Soos, K. Siddle, J. Olefsky, A. Ullrich, D.A. McClain, and J.E. Pessin, Transdominant inhibition of tyrosine kinase activity in mutant insulin/inulin-like growth factor I hybrid receptors, Proc. Natl. Acad. Sci. ,USA. 88:214–218 (1991).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pessin, J.E. (1994). Molecular Properties of Insulin/IGF-1 Hybrid Receptors 4th International Symposium on Insulin, IGFs and Their Receptors. In: Le Roith, D., Raizada, M.K. (eds) Current Directions in Insulin-Like Growth Factor Research. Advances in Experimental Medicine and Biology, vol 343. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2988-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2988-0_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6301-9
Online ISBN: 978-1-4615-2988-0
eBook Packages: Springer Book Archive